GPhC defends questions in pre-reg exams

摘要

The General Pharmaceutical Council (GPhC) has defended the questions it set for June's preregistration exam after hundreds of students complained. In its review of this summer's exams, the GPhC's Board of Assessors said: 'all questions are subject to a rigorous, multi-stage review process before they are included in a paper. However, [...] questions which are ambiguous or otherwise perform unsatisfactorily are removed after a sitting.'